mRNA Vaccine Test Rats Born Deformed



[INSIDE JW]

Decorated Veteran and FBI Analyst Sues FBI after Falsely Being Accused
of Disloyalty to the United States

[[link removed]]
This week, we filed a lawsuit on behalf of FBI analyst Marcus Allen
in the U.S. District Court for the District of South Carolina against
FBI Director Christopher Wray for violating Allen’s constitutional
rights by falsely accusing him of holding “conspiratorial views,”
stripping his security clearance, and suspending him from duty without
pay (_Marcus O. Allen v Christopher Wray_
[[link removed]]
(No. 22-cv-4536)).

The FBI revoked his security clearance because apparently, the FBI
believes that any views contrary to its own regarding what occurred on
January 6 constitutes disloyalty to the United States.

The new lawsuit details Allen’s outstanding military and FBI
service:

> Because of his outstanding military service, [Allen] was awarded the
> Navy and Marine Corps Commendation Medal and the Navy and Marine
> Corps Achievement Medal. In 2004, [Allen] was designated the Marine
> Corps Intelligence Activity Runner-Up for Intelligence NCO of the
> year.

***

> In 2015, [Allen] joined the FBI as a staff operations specialist.
> Among other tasks, he has provided ad hoc all-source analytical
> support to the FBI Charlotte Field Office Joint Terrorism Task
> Force. He has consistently been rated “Exceeds Fully Successful”
> on his FBI performance evaluations. He received the FBI Charlotte
> Field Office Employee of the Year Award in 2019.

> [Allen] first received a Top Secret security clearance in early
> 2001.
Despite Allen’s exemplary service, in a January 10, 2022, letter
[[link removed]]
the FBI asserted:

> The Security Division has learned you have espoused conspiratorial
> views both orally and in writing and promoted unreliable information
> which indicates support for the events of January 6th. These
> allegations raise sufficient concerns about your allegiance to the
> United States and your judgment to warrant a suspension of your
> clearance pending further investigation.
In a February 17, 2022, letter the FBI further notified Allen that he
was being placed on administrative leave without pay due to the
suspension of his security clearance.

The lawsuit states:

> [Allen’s] allegiance is to the United States, as he has
> demonstrated during his years of exemplary military and law
> enforcement service to his country.
>
> [Allen] was not involved in the events of January 6 and did not
> support them in any material way. The FBI has made no allegation
> or offered any evidence to the contrary.
>
> [Allen] has expressed no view that could be reasonably interpreted
> as personally expressing support or sympathy for any unlawful
> activity that occurred on January 6.
>
> The FBI has not identified any specific statements or actions
> supporting its contention that Plaintiff has done otherwise.
We contend that the FBI did not give Allen a chance to clear himself,
despite his repeated inquiries. In early May 2022, however, the FBI
requested that Allen appear for an interview. He promptly complied.
The interview request came only days after FBI Director Wray was
confronted by members of Congress over concerns that the FBI was
weaponizing the security clearance process to target politically
conservative employees. Since that time, Allen has received no further
word on the status of the FBI’s investigation.

On June 7, 2022, Rep. Jim Jordan, ranking member of the House
Judiciary Committee, sent a letter
[[link removed]]
to Wray regarding the firing of FBI employees, noting that,
“Multiple whistleblowers have called it a ‘purge’ of FBI
employees holding conservative views.”

The lawsuit alleges several violations of Allen’s First and Fifth
Amendment rights and asks that Allen’s security clearance and
employment be restored.

The FBI can’t purge employees based on political smears. We are
reminding the FBI that it is not above the law with this civil rights
lawsuit for Mr. Allen, a decorated Marine veteran and highly regarded
FBI employee.

FDA RECORDS: SIGNIFICANT NUMBER OF MRNA TEST RATS BORN WITH SKELETAL
DEFORMATIONS

We continue to investigate the government’s approval of the COVID
vaccines.

Most recently, we received 699 pages
[[link removed]]
of records from the Department of Health and Human Services regarding
data Moderna submitted to the FDA on its mRNA COVID-19 vaccine, which
indicate a “statistically significant” number of rats were born
with skeletal deformations after their mothers were injected with the
vaccine.

The documents also reveal Moderna elected not to conduct a number of
standard pharmacological studies on the laboratory test animals.

We obtained the records through a September 2021 FOIA lawsuit
[[link removed]]
we filed after the FDA,
the Centers for Disease Control and Prevention and the National
Institute for Allergy and Infectious Disease (NIAID) failed to respond
to a June 2021 FOIA request biodistribution studies and related data
for the Pfizer, Moderna and Johnson & Johnson COVID vaccines
(_Judicial Watch v. U.S. Department of Health and Human Services_
[[link removed]
_(No. 1:21-cv-02418)).

These previously hidden records about the COVID-19 vaccine safety and
efficacy studies raise a number of disturbing questions. The fact that
it has taken a federal lawsuit to get access to this material is yet
another scandal.

The records include a “Nonclinical Overview
[[link removed]
prepared by Moderna and submitted to the FDA for approval of its
vaccine revealing that a number of rats were born with skeletal
deformations, known as “wavy ribs” and “rib nodules,” to
mothers injected with the mRNA vaccine. The study dismissed the
anomalies as “not considered adverse:”

> mRNA-1273-related variations in skeletal examination included
> statistically significant increases in the number of F1 rats with 1
> or more wavy ribs and 1 or more rib nodules. Wavy ribs appeared in 6
> fetuses and 4 litters with a fetal prevalence of 4.03% and a litter
> prevalence of 18.2%. Rib nodules appeared in 5 of those 6 fetuses.
> Skeletal variations are structural changes that do not impact
> development or function of a developing embryo, are considered
> reversible, and often correlate with maternal toxicity and/or lack
> of other indicators of developmental toxicity (Carney and Kimmel
> 2007). Maternal toxicity in the form of clinical observations was
> observed for 5 days following the last dose (GD 13), correlating
> with the most sensitive period for rib development in rats (GDs 14
> to 17). Furthermore, there were no other indicators of
> mRNA-1273-related developmental toxicity observed, including delayed
> ossification; therefore, these common skeletal variations were not
> considered adverse.
(Non-adverse deformations receive a different perspective in the July
2009 _Environmental Research_ article, “Dose–response
relationships of rat fetal skeleton variations: Relevance for risk
assessment
[[link removed]


> (Whether or not a substance-induced increase in the incidence of
> fetal skeleton variations should be taken into account for human
> risk assessment is a long-standing controversial issue. It has been
> argued that chemical-produced increases in variations are not to be
> considered for risk assessment because they are “unlikely to
> adversely affect survival or health.” The counter argument is that
> even not being overtly adverse and conveying no apparent selective
> disadvantage, a treatment-induced increase in the occurrence of
> variations means that the chemical agent has the potential to
> perturb skeleton development. According to this view, under a
> different condition of exposure, or in another species, this
> perturbation of normal bone formation may give rise to a different
> and more severe outcome.))
A “Pharmacokinetics Written Summary
[[link removed]
marked “Confidential,” indicates that the information it contains
is related to the mRNA-1273 (Moderna vaccine) strain; however, much of
the data comes from work with mRNA-1647. The study states:

> The results of a biodistribution study of mRNA-1647 support the
> development of mRNA-1273.

***

> The biodistribution of mRNA-1647 was evaluated in a non-Good
> Laboratory Practice (GLP), single-dose, intramuscular (IM) injection
> study in Sprague Dawley rats…. mRNAs that are within an LNP of the
> same composition (e.g., mRNA-1273 and mRNA-1647) are expected to
> distribute similarly.
mRNA-1273 is Moderna’s covid vaccine, which was delivered
[[link removed]]
to the National Institutes of Health in February 2020 for study.
mRNA-1647
[[link removed]]
is a previously developed vaccine for the cytomegalovirus.

The “Summary” indicates
[[link removed]


* No absorption studies with mRNA-1273 [used in Moderna’s COVID
vaccine
[[link removed]]]
have been performed.
* No metabolism studies with mRNA-1273 have been performed.
* No excretion studies with mRNA-1273 have been performed.
* No PK [pharmacokinetic
[[link removed]]]
studies with
mRNA-1273 have been performed.
* No other PK studies with mRNA-1273 have been performed.

(According to PubMed.gov
[[link removed]],
“Pharmacokinetics studies are performed to clarify the absorption,
distribution, metabolism, and excretion of drug candidates…[and] are
required for establishing the efficacy and safety in humans.”)

A separate study
[[link removed]]
submitted to the FDA sponsored by Moderna Therapeutics Inc. and
conducted by Charles River Laboratories in Montreal, Canada, is titled
“A Single Dose Intramuscular Injection Tissue Distribution Study of
mRNA-1647 in Male Sprague-Dawley Rats” in which “[t]he objective
… was to determine the tissue distribution of mRNA-1647,” as
opposed to mRNA-1273 used in Moderna’s COVID vaccine
[[link removed]].

In one appendix to the study, a “clarification” was issued in the
toxicokinetic report regarding the half-life of mRNA injected into the
rats, noting: “The average value of terminal half-life for the
muscle (i.e. injection site) in Sections 4.2 and 5 of the
toxicokinetic report should be read 14.9 [hours] instead of 8.39
[hours] based on the results of the toxicokinetic evaluation.”

The study further notes that the wording of the conclusion was
modified to read, “The half-life … of mRNA-1647 was reliably
estimated in muscle (site of injection), proximal popliteal and
axillary distal lymph nodes, and spleen with average values for all
construct t½ [half-life] of 14.9 8.39, 34.8, 31.1 and 63.0 hours,
respectively.” [Emphasis in original]

Another appendix, titled “Summary Mean (±SE) mRNA-1647
Pharmacokinetic Parameters in Sprague-Dawley Rat in Plasma and Tissues
Following 100μg Intramuscular Injection Administration of mRNA-1647
on Day 1,” reveals that, in addition to distributing to the muscle
site, lymph nodes and spleen, the mRNA particles also distributed to
the bone marrow, brain, eyes, heart, liver, lungs, stomach and testes.

A separate study
[[link removed]]
indicates that the mRNA-1647 particles injected into rats were
“observed in muscle (i.e. site of injection), followed by proximal
(popliteal) lymph nodes, axillary lymph nodes and spleen, suggesting
the mRNA-1647 distribution to the circulation by lymph flow.” (The
mRNA was delivered via “lipid nanoparticle dispersion.”)

Through FOIA we have uncovered a substantial amount of information
regarding COVID-19 issues:

* In October 2020, we received FDA records that detailed pressure
[[link removed]]
for
COVID-19 vaccine booster approval and use.
* NIH records revealed
[[link removed]]
an FBI
“inquiry” into the NIH’s controversial bat coronavirus grant
tied to the Wuhan Institute of Virology. The records also show
National Institute of Allergy and Infectious Diseases (NIAID)
officials were concerned about “gain-of-function” research in
China’s Wuhan Institute of Virology in 2016. The Fauci agency was
also concerned about EcoHealth Alliance’s
[[link removed]]
lack of compliance with reporting
rules and use of gain-of-function research in the NIH-funded research
involving bat coronaviruses in Wuhan, China.
* HHS records revealed that from 2014 to 2019, $826,277
[[link removed]]
was given to the
Wuhan Institute of Virology for bat coronavirus research by the NIAID.
* NIAID records showed that it gave nine China-related grants to
EcoHealth Alliance
[[link removed]]
to research
coronavirus emergence in bats and was the NIH’s top issuer of grants
to the Wuhan lab itself. The records also included an email from the
vice director of the Wuhan Lab asking an NIH official for help finding
disinfectants for decontamination of airtight suits and indoor
surfaces.
* HHS records included an “urgent for Dr. Fauci
[[link removed]]
” email chain,
citing ties between the Wuhan lab and the taxpayer-funded EcoHealth
Alliance
[[link removed]].
The government emails
also reported that the foundation of U.S. billionaire Bill Gates
worked closely with the Chinese government to pave the way for
Chinese-produced medications to be sold outside China and help
“raise China’s voice of governance by placing representatives from
China on important international counsels as high level commitment
from China.”
* HHS records included a grant application for research involving
the coronavirus that appears to describe “gain-of-function
[[link removed]
research involving RNA extractions from bats, experiments on viruses,
attempts to develop a chimeric virus and efforts to genetically
manipulate the full-length bat SARSr-CoV WIV1 strain molecular clone.
* HHS records showed the State Department and NIAID knew immediately
in January 2020 that China was withholding COVID data
[[link removed]],
which was
hindering risk assessment and response by public health officials.
* University of Texas Medical Branch (UTMB) records
[[link removed]]
show the former director of the Galveston National Laboratory at the
University of Texas Medical Branch (UTMB), Dr. James W. Le Duc
[[link removed]]
warned Chinese
researchers at the Wuhan Institute of Virology of potential
investigations into the COVID issue by Congress.
* HHS records regarding biodistribution studies and related data for
the COVID-19 vaccines show a key component of the vaccines developed
by Pfizer/BioNTech, lipid nanoparticles (LNPs), were found outside the
injection site
[[link removed]],
mainly the liver, adrenal glands, spleen and ovaries of test animals,
eight to 48 hours after injection.
* Records from the Federal Select Agent Program (FSAP) reveal safety
lapses
[[link removed]]
and violations at U.S. biosafety laboratories that conduct research on
dangerous agents and toxins.
* HHS records include emails
[[link removed]]
between National Institutes of Health (NIH) then-Director Francis
Collins
[[link removed]]
and Anthony
Fauci, the director of National Institute of Allergy and Infectious
Diseases (NIAID), about hydroxychloroquine and COVID-19.
* HHS records show that NIH officials tailored confidentiality forms
[[link removed]]
to China’s terms
and that the World Health Organization (WHO) conducted an unreleased,
“strictly confidential” COVID-19 epidemiological analysis in
January 2020.
* Fauci emails
[[link removed]]
include
his approval of a press release supportive of China’s response to
the 2019 novel coronavirus.

DRIVER’S LICENSE SECURITY LAW DELAYED ANOTHER TWO YEARS OVER COVID

The Biden administration is not in a hurry to enact a commonsense
safeguard
[[link removed]],
adopted
after the 9/11 attack in 2001, to protect against the misuse of
driver’s licenses by terrorists. Two decades later, we’re still
waiting, as our _Corruption Chronicles_ blog reports
[[link removed]].


More than two decades after the worst terrorist attack on U.S. soil,
the Biden administration is using COVID-19 as an excuse to further
delay enforcement of a law requiring minimum security standards for
driver’s licenses and identification cards. The measure, known as
the REAL ID Act
[[link removed]],
was
passed by Congress after 9/11 to establish a more secure national
system less prone to fraud after several of the hijackers exploited
loopholes to obtain dozens of driver’s licenses from various states.
The cards allowed them to take flight lessons and board planes to
carry out the 2001 attacks. At the recommendation of the 9/11
Commission
[[link removed]]
Congress passed the
law in 2005 and states originally had until 2011 to comply, though the
Obama administration tried to drastically weaken the legislation.
Obama Homeland Security Secretary Janet Napolitano granted a 20-month
extension on the deadline as she worked behind the scenes to undermine
[[link removed]]
the
REAL ID Act, asserting that it violates civil liberties and privacy.

In the fall of 2020 the Department of Homeland Security (DHS)
announced
[[link removed]]
that, after multiple delays, all 50 states were finally in full
compliance with the REAL ID Act with most states becoming compliant
under pressure from the Trump administration. “To date, the 50
states have issued more than 105 million REAL ID-compliant driver’s
licenses and identification cards, representing 38 percent of all
driver’s licenses and identification card holders,” DHS revealed
at the time. In less than a year full enforcement of REAL ID will take
effect at all federally regulated airports, federal facilities, and
nuclear power plants, the 2020 bulletin further states. That means
federal agencies, such as the Transportation Security Administration
(TSA), will be prohibited from accepting licenses and ID cards that do
not meet the law’s standards. Though it was welcome news at the
time, it was still outrageous that it took 15 years after Congress
passed the legislation to protect national security.

This month, the Biden administration is extending REAL ID full
enforcement for another two years to give states more time to ensure
residents have driver’s licenses and identification cards that meet
the law’s security standards. “The extension is necessary, in
part, to address the lingering impacts of the COVID-19 pandemic on the
ability to obtain a REAL ID driver’s license or identification
card,” according to a DHS notice
[[link removed]]
issued last week. The pandemic hindered REAL ID progress, the agency
writes, because state driver’s licensing agencies had to work
through backlogs and many automatically extended license expiration
dates and shifted operations to appointment only. Keep in mind the
agencies had more than enough time to comply before COVID. Rest
assured however, DHS continues to work closely with states to finally
meet REAL ID requirements, according to Secretary Alejandro Mayorkas.
“We will continue to ensure that the American public can travel
safely,” Mayorkas said.

The continued delays are inexcusable considering what is at stake. The
measure’s crucial verification process requires states to certify
the authenticity of every driver’s license applicant by requiring
that documents, such as a birth certificate or passport, be submitted
to get the card are legitimate and that the applicant is in the United
States legally. It also calls for a newly created federal database to
link all licensing information that must be checked before states
issue new cards. This will establish a much-needed standardized
national driver’s license system less vulnerable to fraud and will
prevent terrorists from abusing it as did September 11 hijackers. Once
the law is fully enforced, federal agencies will be prohibited from
accepting driver’s licenses or ID cards from noncompliant states for
official purposes, including boarding an aircraft, accessing a federal
facility, and entering a nuclear power plant.

It is not clear how the Biden administration plans to handle the dozen
states—including Arkansas, California, Maine, and Oregon as well as
the District of Columbia—that offer gender-neutral licenses and ID
cards in violation of the REAL ID Act. Title II of the act
specifically states that “features on each driver’s license and
identification card issued to a person by the State” must include:
The person’s full legal name; the person’s date of birth; the
person’s gender; the person’s driver’s license or identification
card number; a digital photograph of the person; the person’s
address of principle residence; the person’s signature; physical
security features designed to prevent tampering, counterfeiting or
duplication of the document for fraudulent purposes; a common
machine-readable technology with defined minimum data elements.
Until next week,





[Contribute]
[[link removed]]


<a
href="[link removed]"
target="_blank"><img
src="[link removed]"
style="width:100%;height:auto;" alt="advertisement"></a>

[32x32x1]
[[link removed]]

[32x32x2]
[[link removed]]

[32x32x3]
[[link removed]]

[32x32x3]
[[link removed]]

Judicial Watch, Inc.
425 3rd St Sw Ste 800
Washington, DC 20024

202.646.5172



© 2017 - 2022, All Rights Reserved
Manage Email Subscriptions
[[link removed]]
|
Unsubscribe
[[link removed]]

View in browser
[[link removed]]